We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
401
DELISTED
Marathon Oil Corporation
MRO
| $6.21M | 0.03% |
392,820
+12,056
| +3% | +$198K |
|
402
Vanguard Small-Cap Value ETF
VBR
$37.1B
| $6.1M | 0.03% |
49,636
+3,762
| +8% | +$462K |
|
403
iShares Russell 1000 Value ETF
IWD
$82B
| $6.08M | 0.03% |
52,862
+2,227
| +4% | +$255K |
|
404
Zimmer Biomet
ZBH
$17.7B
| $6.06M | 0.03% |
51,189
+5,123
| +11% | +$581K |
|
405
Targa Resources
TRGP
$60.4B
| $6.06M | 0.03% |
101,189
+16,220
| +19% | +$942K |
|
406
Deere & Co
DE
$170B
| $5.97M | 0.03% |
54,854
-651
| -1% | -$70.5K |
|
|
CMA
407
DELISTED
Comerica
CMA
| $5.97M | 0.03% |
87,024
+32,190
| +59% | +$2.25M |
|
408
Host Hotels & Resorts
HST
$16.8B
| $5.96M | 0.03% |
319,355
+55,226
| +21% | +$1.01M |
|
|
VAR
409
DELISTED
Varian Medical Systems, Inc.
VAR
| $5.94M | 0.03% |
65,198
-25,317
| -28% | -$2.11M |
|
410
Carnival Corporation Ltd
CCL
$36.1B
| $5.88M | 0.03% |
99,919
-39,155
| -28% | -$2.19M |
|
411
Netflix
NFLX
$292B
| $5.67M | 0.03% |
383,530
+12,210
| +3% | +$171K |
|
412
Nasdaq
NDAQ
$51.5B
| $5.59M | 0.03% |
241,455
-44,523
| -16% | -$1.03M |
|
413
KeyCorp
KEY
$24.3B
| $5.58M | 0.03% |
313,681
-2,725
| -0.9% | -$49.9K |
|
|
JWN
414
DELISTED
Nordstrom
JWN
| $5.56M | 0.03% |
119,491
-11,296
| -9% | -$505K |
|
415
Prudential Financial
PRU
$41.7B
| $5.54M | 0.03% |
51,950
+22,470
| +76% | +$2.42M |
|
416
Public Service Enterprise Group
PEG
$39.8B
| $5.44M | 0.03% |
122,716
+29,315
| +31% | +$1.29M |
|
|
MON
417
DELISTED
Monsanto Co
MON
| $5.42M | 0.03% |
47,927
-4,138
| -8% | -$458K |
|
418
Graco
GGG
$12.9B
| $5.41M | 0.03% |
172,353
-129,993
| -43% | -$3.92M |
|
419
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $5.38M | 0.03% |
17,215
-991
| -5% | -$308K |
|
420
RELX
RELX
$60.1B
| $5.29M | 0.03% |
267,071
-8,261
| -3% | -$154K |
|
421
Align Technology
ALGN
$12B
| $5.28M | 0.03% |
46,006
-1,008
| -2% | -$102K |
|
422
International Flavors & Fragrances
IFF
$19.4B
| $5.22M | 0.02% |
39,391
+870
| +2% | +$107K |
|
423
Old Republic International
ORI
$10.3B
| $5.14M | 0.02% |
251,126
-4,225
| -2% | -$85.3K |
|
424
Capri Holdings
CPRI
$1.77B
| $5.08M | 0.02% |
133,310
-506,914
| -79% | -$19.9M |
|
425
Nucor
NUE
$56.4B
| $5.05M | 0.02% |
84,660
+497
| +0.6% | +$30.4K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.